Nirvanol
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Other names | 5-Ethyl-5-phenylhydantoin |
| Routes of administration |
By mouth |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.010.138 |
| Chemical and physical data | |
| Formula | C11H12N2O2 |
| Molar mass | 204.22518 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Nirvanol, also known as ethylphenylhydantoin, is a derivative of hydantoin with anticonvulsant properties. Its 5-ethyl-5-phenyl substitution pattern is similar to that of phenobarbital. It is useful in the treatment of chorea.
Metabolism
Metabolism of nirvanol is stereoselective, with the (S)- enantiomer undergoing roughly 14 times more hydroxylation at the 4 position of the phenyl group than the (R)-enantiomer.
External links
- Comparative Toxicogenomics Database: ethylphenylhydantoin
- MeSH Supplementary Concept Data: ethylphenylhydantoin